Advertisement
Screener

CRONOS GROUP INC. (CRON) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

CRONOS GROUP INC. Operating Cash Flow

CRONOS GROUP INC. (CRON) reported Operating Cash Flow of $34.91 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06

  • CRONOS GROUP INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $24.01M, a 752.02% increase year-over-year.
  • CRONOS GROUP INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $10.90M.
  • CRONOS GROUP INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $11.84M, a 53.30% increase year-over-year.
  • CRONOS GROUP INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $13.31M, a 14.90% increase year-over-year.
  • CRONOS GROUP INC. net cash provided by (used in) operating activities for fiscal 2025 was $25.87M, a 37.27% increase from fiscal 2024.
  • CRONOS GROUP INC. net cash provided by (used in) operating activities for fiscal 2024 was $18.84M.
  • CRONOS GROUP INC. net cash provided by (used in) operating activities for fiscal 2023 was -$42.84M.
  • CRONOS GROUP INC. net cash provided by (used in) operating activities for fiscal 2022 was -$88.95M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2026-06-30$24.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$34.91M
10-Q · filed 2026-08-06
$46.74M
derived: sum of 3 quarters · filed 2026-08-06
$60.05M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$10.90M
10-Q · filed 2026-05-11
$22.73M
derived: sum of 2 quarters · filed 2026-05-11
$36.04M
derived: sum of 3 quarters · filed 2026-05-11
$38.86M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$11.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$25.14M
derived: sum of 2 quarters · filed 2026-02-26
$27.96M
derived: sum of 3 quarters · filed 2026-08-06
$25.87M
10-K · filed 2026-02-26
2025-09-30$13.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$16.13M
derived: sum of 2 quarters · filed 2026-08-06
$14.03M
10-Q · filed 2025-11-06
$21.75M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$2.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$722.00K
10-Q · filed 2026-08-06
$8.44M
derived: sum of 3 quarters · filed 2026-08-06
$20.02M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$2.10M
10-Q · filed 2026-05-11
$5.62M
derived: sum of 2 quarters · filed 2026-05-11
$17.21M
derived: sum of 3 quarters · filed 2026-05-11
$18.95M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31$7.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$19.30M
derived: sum of 2 quarters · filed 2026-02-26
$21.05M
derived: sum of 3 quarters · filed 2026-02-26
$18.84M
10-K · filed 2026-02-26
2024-09-30$11.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$13.33M
derived: sum of 2 quarters · filed 2025-11-06
$11.12M
10-Q · filed 2025-11-06
$27.94M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$1.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$460.00K
10-Q · filed 2025-08-07
$16.36M
derived: sum of 3 quarters · filed 2026-02-26
$16.17M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$2.20M
10-Q · filed 2025-05-08
$14.61M
derived: sum of 2 quarters · filed 2026-02-26
$14.43M
derived: sum of 3 quarters · filed 2026-02-26
$2.65M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$16.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$16.63M
derived: sum of 2 quarters · filed 2026-02-26
$4.86M
derived: sum of 3 quarters · filed 2026-02-26
-$42.84M
10-K · filed 2026-02-26
2023-09-30-$183.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$11.96M
derived: sum of 2 quarters · filed 2024-11-12
-$59.65M
10-Q · filed 2024-11-12
-$84.02M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$11.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$59.47M
10-Q · filed 2024-08-08
-$83.84M
derived: sum of 3 quarters · filed 2025-02-27
-$97.22M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$47.69M
10-Q · filed 2024-05-09
-$72.06M
derived: sum of 2 quarters · filed 2025-02-27
-$85.45M
derived: sum of 3 quarters · filed 2025-02-27
-$102.73M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$24.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$37.76M
derived: sum of 2 quarters · filed 2025-02-27
-$55.04M
derived: sum of 3 quarters · filed 2025-02-27
-$88.95M
10-K · filed 2025-02-27
2022-09-30-$13.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$30.66M
derived: sum of 2 quarters · filed 2023-11-08
-$64.58M
10-Q · filed 2023-11-08
-$100.51M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30-$17.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$51.19M
10-Q · filed 2023-08-08
-$87.13M
derived: sum of 3 quarters · filed 2024-02-29
-$118.61M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$33.91M
10-Q · filed 2023-05-09
-$69.85M
derived: sum of 2 quarters · filed 2024-02-29
-$101.33M
derived: sum of 3 quarters · filed 2024-02-29
-$140.91M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31-$35.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$67.42M
derived: sum of 2 quarters · filed 2024-02-29
-$107.00M
derived: sum of 3 quarters · filed 2024-02-29
-$153.62M
10-K · filed 2024-02-29
2021-09-30-$31.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
-$71.06M
derived: sum of 2 quarters · filed 2022-11-07
-$117.68M
10-Q · filed 2022-11-07
-$156.01M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30-$39.58M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$86.20M
10-Q · filed 2022-08-09
-$124.53M
derived: sum of 3 quarters · filed 2023-02-28
-$152.69M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31-$46.62M
10-Q · filed 2022-05-10
-$46.00M
10-Q · filed 2021-05-07
-$84.94M
derived: sum of 2 quarters · filed 2023-02-28
-$113.11M
derived: sum of 3 quarters · filed 2023-02-28
-$152.59M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$38.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$66.49M
derived: sum of 2 quarters · filed 2023-02-28
-$105.97M
derived: sum of 3 quarters · filed 2023-02-28
-$144.87M
10-K · filed 2023-02-28
-$142.46M
10-K · filed 2021-02-26
2020-09-30-$28.17M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-02-18
-$67.64M
derived: sum of 2 quarters · filed 2022-02-18
-$106.54M
10-Q · filed 2022-02-18
-$104.68M
10-Q · filed 2020-11-05
-$160.94M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30-$39.48M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-02-18
-$78.38M
10-Q/A · filed 2022-02-18
-$77.19M
10-Q · filed 2020-08-06
-$132.78M
derived: sum of 3 quarters · filed 2022-03-01
-$152.80M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$38.90M
10-Q · filed 2021-05-07
-$93.30M
derived: sum of 2 quarters · filed 2022-03-01
-$113.32M
derived: sum of 3 quarters · filed 2022-03-01
-$156.25M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$54.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$74.42M
derived: sum of 2 quarters · filed 2022-03-01
-$117.36M
derived: sum of 3 quarters · filed 2022-03-01
-$131.19M
10-K · filed 2022-03-01
-$130.01M
10-K/A · filed 2020-03-30
2019-09-30-$20.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$62.95M
derived: sum of 2 quarters · filed 2020-11-05
-$76.79M
10-Q · filed 2020-11-05
2019-06-30-$42.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$56.77M
10-Q · filed 2020-08-06
2019-03-31-$13.84M
10-Q · filed 2020-05-08
2018-12-31-$7.52M
10-K · filed 2021-02-26
2017-12-31-$4.28M
10-K/A · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87